Table 3– Laboratory, surfactant protein B (SPB) and plasma receptor for advanced glycation end products (RAGE) data in the study population
VariablesBefore surgeryAfter CPBAfter 24 hAfter 48 hANOVA
Hb mg·dL−113.8±1.69.8±1.6**9.5±1.3++p<0.001
Hct %39±527±5**27±4++p<0.001
WBC u·109·L−17.3±1.410.9±2.8**11.9±3.7++p<0.001
Neutrophil %63.1±8.481.5±5.0**79.3±5.5++ ƒƒp<0.001
Total proteins g·dL−15.27±0.623.05±0.59##3.72±0.55**,¶¶4.12±0.7++,§§,ƒƒp<0.001
LDH mg·dL−1232±130364±171**347±175++p<0.001
SPB 40 kDa ratio11.63 (2.4)##1.58 (2.2)**1.01 (0.66) §§,ƒƒ
SPB 8 kDa ng·mL−15587 (3089)20307 (19873)##6154 (5788)¶¶4810 (3340) §§,ƒƒ
SPBN 8 kDa ng·mg−1112 (62)644 (758)##184 (103)**,¶¶125 (66) §§,ƒƒ
RAGE pg·mL−1633 (575)1361 (216)##508 (216)**,¶¶417 (247) ++,§§,ƒƒ
RAGEN pg·mg−113.5 (9.2)42.6 (24.4)##13.0 (6.8)¶¶10.2 (6.2) ++,§§,ƒƒ
  • Data are presented as mean±sd or as median (75th–25th interquartile difference), unless otherwise stated. Hb: haemoglobin; Hct: haematocrit; WBC: white blood cell; LDH: lactate dehydrogenase; SPBN: SPB normalised for total protein amount; RAGEN: RAGE normalised for total protein amount. ##: p<0.01 after CPB versus before surgery; **: p<0.01 after 24 h versus before surgery; ¶¶: p<0.01 after 24 h versus after CPB; ++: p<0.01 after 48 h versus before surgery; §§: p<0.01 after 48 h versus after CPB; ƒƒ: p<0.01 after 48 h versus after 24 h.